Federal Register / Vol. 70, No. 206 / Wednesday, October 26, 2005 / Notices 61827 

FEDERAL RESERVE SYSTEM 

Notice of Proposals to Engage in 

Permissible Nonbanking Activities or 

to Acquire Companies that are 

Engaged in Permissible Nonbanking 

Activities 

The companies listed in this notice 

have given notice under section 4 of the 

Bank Holding Company Act (12 U.S.C. 

1843) (BHC Act) and Regulation Y (12 

CFR Part 225) to engage de novo, or to 

acquire or control voting securities or 

assets of a company, including the 

companies listed below, that engages 

either directly or through a subsidiary or 

other company, in a nonbanking activity 

that is listed in § 225.28 of Regulation Y 

(12 CFR 225.28) or that the Board has 

determined by Order to be closely 

related to banking and permissible for 

bank holding companies. Unless 

otherwise noted, these activities will be 

conducted throughout the United States. 

Each notice is available for inspection 

at the Federal Reserve Bank indicated. 

The notice also will be available for 

inspection at the offices of the Board of 

Governors. Interested persons may 

express their views in writing on the 

question whether the proposal complies 

with the standards of section 4 of the 

BHC Act. Additional information on all 

bank holding companies may be 

obtained from the National Information 

Center website at www.ffiec.gov/nic/. 

Unless otherwise noted, comments 

regarding the applications must be 

received at the Reserve Bank indicated 

or the offices of the Board of Governors 

not later than November 10, 2005. 

A. Federal Reserve Bank of Atlanta 

(Andre Anderson, Vice President) 1000 

Peachtree Street, N.E., Atlanta, Georgia 

30303: 

1. Chestatee Bancshares, Inc., 

Dawsonville, Georgia, to continue to 

engage through Chestatee Financial 

Services, Inc., Dawsonville, Georgia, in 

securities brokerage activities and the 

sale of insurance in a town of less than 

5,000 persons, pursuant to sections 

225.28(b)(7)(i) and 225.28(b)(11)(iii)(A) 

of Regulation Y. 

Board of Governors of the Federal Reserve 

System, October 21, 2005. 

Jennifer J. Johnson, 

Secretary of the Board. 

[FR Doc. E5–5955 Filed 10–25–05; 8:45 am] 

BILLING CODE 6210–01–S 

FEDERAL RESERVE SYSTEM 

Sunshine Act Meeting 

AGENCY HOLDING THE MEETING: Board of 

Governors of the Federal Reserve 

System. 

TIME AND DATE: 12 p.m., Monday, 

October 31, 2005. 

PLACE: Marriner S. Eccles Federal 

Reserve Board Building, 20th and C 

Streets, NW., Washington, DC 20551. 

STATUS: Closed. 

MATTERS TO BE CONSIDERED: 

1. Personnel actions (appointments, 

promotions, assignments, 

reassignments, and salary actions) 

involving individual Federal Reserve 

System employees. 

2. Any items carried forward from a 

previously announced meeting. 

FOR FURTHER INFORMATION CONTACT: 

Michelle A. Smith, Director, Office of 

Board Members; 202–452–2955. 

SUPPLEMENTARY INFORMATION: You may 

call 202–452–3206 beginning at 

approximately 5 p.m. two business days 

before the meeting for a recorded 

announcement of bank and bank 

holding company applications 

scheduled for the meeting; or you may 

contact the Board’s Web site at http:// 

www.federalreserve.gov for an electronic 

announcement that not only lists 

applications, but also indicates 

procedural and other information about 

the meeting. 

Board of Governors of the Federal Reserve 

System, October 21, 2005. 

Robert deV. Frierson, 

Deputy Secretary of the Board. 

[FR Doc. 05–21419 Filed 10–21–05; 4:16pm] 

BILLING CODE 6210–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

[Document Identifier: OS–0990–0263] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Office of the Secretary, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Office of the Secretary (OS), Department 

of Health and Human Services, is 

publishing the following summary of 

proposed collections for public 

comment. Interested persons are invited 

to send comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

#1 Type of Information Collection 

Request: Extension of Currently 

Approved Collection; 

Title of Information Collection: 

Protection of Human Subjects 

Assurance Identification/ Institutional 

Review Board (IRB) Certification/ 

Declaration of Exemption; 

Form/OMB No.: OS–0990–0263; 

Use: The Federal Policy for the 

Protection of Human Subjects, known as 

the Common Rule, requires that before 

engaging in non-exempt human subjects 

research that is conducted or supported 

by a Common Rule department or 

agency, each institution must: (1) Hold 

an applicable assurance of compliance 

[Section 103(a)]; and (2) certify to the 

awarding department or agency that the 

application or proposal for research has 

been reviewed and approved by an IRB 

designated in the assurance [Sections 

103(b) and (f)]. 

Frequency: Reporting on occasion; 

Affected Public: Federal, State, local, 

or tribal governments, business or other 

for-profit, not-for-profit institutions and 

individuals or households; 

Annual Number of Respondents: 

5,000; 

Total Annual Responses: 166,667; 

Average Burden Per Response: 0.25 

hours; 

Total Annual Hours: 41,667; 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access the HHS Web 

site address at http://www.hhs.gov/ 

oirm/infocollect/pending/ or e-mail your 

request, including your address, phone 

number, OMB number, and OS 

document identifier, to 

naomi.cook@hhs.gov, or call the Reports 

Clearance Office on (202) 690–6162. 

Written comments and 

recommendations for the proposed 

information collections must be mailed 

within 30 days of this notice directly to 

the Desk Officer at the address below: 

OMB Desk Officer: John Kraemer, OMB 

Human Resources and Housing Branch, 

Attention: (OMB #0990–0263), New 

Executive Office Building, Room 10235, 

Washington, DC 20503. 

61828 Federal Register / Vol. 70, No. 206 / Wednesday, October 26, 2005 / Notices 

Dated: October 17, 2005. 

Robert E. Polson, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 05–21356 Filed 10–25–05; 8:45 am] 

BILLING CODE 4168–17–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel; Meeting 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Enhancing Utilization 

of Childhood Immunization Client 

Recall Practices by Private Providers, 

RFA; IP 05–088; Improving Vaccination 

Coverage in the Greater than 65 Years of 

Age Population, RFA IP 05–091; 

Influenza Vaccination of Children and 

Accompanying Adults: Mass 

Vaccination versus Vaccination in 

Routine Care, RFA IP 05–094; 

Effectiveness of a Hospital Based 

Program for Vaccination of Birth 

Mothers and Household Contacts with 

Inactivated Influenza Vaccine, RFA; IP 

05–095; and Developing Methods and 

Strategies to Increase Use of 

Immunization Registries by Private 

Providers, RFA IP 05–096. 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting: 

Name: Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Enhancing 

Utilization of Childhood Immunization 

Client Recall Practices by Private 

Providers, RFA IP 05–088; Improving 

Vaccination Coverage in the Greater 

than 65 Years of Age Population, RFA 

IP 05–091; Influenza Vaccination of 

Children and Accompanying Adults: 

Mass Vaccination versus Vaccination in 

Routine Care, RFA IP 05–094; 

Effectiveness of a Hospital Based 

Program for Vaccination of Birth 

Mothers and Household Contacts with 

Inactivated Influenza Vaccine, RFA IP 

05–095; and Developing Methods and 

Strategies to Increase Use of 

Immunization Registries by Private 

Providers, RFA IP 05–096. 

Times and Dates: 8 a.m.–5 p.m., 

November 21, 2005 (Closed). 

Place: Renaissance Hotel, 1 Hartsfield 

Center Parkway, Atlanta, GA 30354, 

Telephone 404.209.9999. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92–

463. 

Matters to be Discussed: The meeting 

will include the review, discussion, and 

evaluation of applications received in 

response to Enhancing Utilization of 

Childhood Immunization Client Recall 

Practices by Private Providers, RFA IP 

05–088; Improving Vaccination 

Coverage in the Greater than 65 Years of 

Age Population, RFA IP 05–091; 

Influenza Vaccination of Children and 

Accompanying Adults: Mass 

Vaccination versus Vaccination in 

Routine Care, RFA IP 05–094; 

Effectiveness of a Hospital Based 

Program for Vaccination of Birth 

Mothers and Household Contacts with 

Inactivated Influenza Vaccine, RFA IP 

05–095; and Developing Methods and 

Strategies to Increase Use of 

Immunization Registries by Private 

Providers, RFA IP 05–096. 

FOR FURTHER INFORMATION CONTACT: 

Horace M. Stiles, PHD MPH DDS, 

Scientific Review Administrator, 

National Institute for Occupational 

Safety and Health, CDC, 1600 Clifton 

Road, NE., MS E–74, Atlanta, GA 30333, 

Telephone 404–498–2584. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: October 19, 2005. 

Alvin Hall, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 05–21341 Filed 10–25–05; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

Vaccines and Related Biological 

Products Advisory Committee; Notice 

of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). At least one portion of the 

meeting will be closed to the public. 

Name of Committee: Vaccines and 

Related Biological Products Advisory 

Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on November 16, 2005, from 8:30 

a.m. to 5:15 p.m. and on November 17, 

2005, from 8:30 a.m. to 5:30 p.m. 

Location: Holiday Inn Select, 8120 

Wisconsin Ave., Bethesda, MD. 

Contact Person: Christine Walsh or 

Denise Royster, Center for Biologics 

Evaluation and Research (HFM–71), 

Food and Drug Administration, 1401 

Rockville Pike, Rockville, MD 20852, 

301–827–0314, or FDA Advisory 

Committee Information Line, 1–800–

741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512391. Please call the Information 

Line for up-to-date information on this 

meeting. 

Agenda: On November 16, 2005, the 

committee will hear presentations and 

discuss the use of Madin-Darby Canine 

Kidney Cells for manufacture of 

Inactivated Influenza Vaccines. On 

November 17, 2005, the committee will 

discuss developing new Pneumococcal 

Vaccines for U.S. licensure for adults. 

Procedure: On November 16, 2005, 

from 8:30 a.m. to 5:15 p.m. and on 

November 17, 2005, from 10 a.m. to 5:30 

p.m., the meeting is open to the public. 

Interested persons may present data, 

information, or views, orally or in 

writing, on issues pending before the 

committee. Written submissions may be 

made to the contact person by 

November 9, 2005. Oral presentations 

from the public will be scheduled on 

November 16, 2005, between 

approximately 1:45 p.m. and 2:15 p.m. 

and on November 17, 2005, between 

approximately 1 p.m. and 1:30 p.m. 

Time allotted for each presentation may 

be limited. Those desiring to make 

formal oral presentations should notify 

the contact person before November 9, 

2005, and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation. 

Closed Committee Deliberations: On 

November 17, 2005, from 8:30 a.m. to 

9:55 a.m., the meeting will be closed to 

permit discussion and review of trade 

secret and/or confidential information 

(5 U.S.C. 552b(c)(4)). 

Persons attending FDA’s advisory 

committee meetings are advised that the